The less-often-traveled surface of stem cells: Caveolin-1 and caveolae in stem cells, tissue repair and regeneration

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Baker, Natasha ^a   Tuan, Rocky S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolae; Caveolin 1; Cholesterol; Regenerative medicine; Signal transduction; Stem cells; Tissue repair

Indexed keywords

CAVEOLIN 1; CHEMOKINE RECEPTOR CXCR4; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1;

ADULT STEM CELL; AGING; CAVEOLA; CELL ACTIVATION; CELL DIFFERENTIATION; CELL HOMING; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; DEGENERATIVE DISEASE; EMBRYONIC STEM CELL; ENDOCYTOSIS; HEMATOPOIETIC STEM CELL; HUMAN; INSULIN RESISTANCE; INTERNALIZATION; LIVER REGENERATION; MECHANOTRANSDUCTION; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL EXPANSION; STEM CELL MOBILIZATION; TISSUE REGENERATION; TISSUE REPAIR; WNT SIGNALING PATHWAY; WOUND HEALING; ANIMAL; GENETICS; METABOLISM; MOUSE; REGENERATION; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; CAVEOLIN 1; CELL DIFFERENTIATION; CELL PROLIFERATION; MICE; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84887945957     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt276     Document Type: Review

References (147)

1. Growth factors, matrices, and forces combine and control stem cells. Discher DE, Mooney DJ, Zandstra PW, Science 2009 324 1673 1677 10.1126/science.1171643 19556500
2. Lipid rafts and signal transduction. Simons K, Toomre D, Nat Rev Mol Cell Biol 2000 1 31 39 10.1038/35036052 11413487
3. Functional rafts in cell membranes. Simons K, Ikonen E, Nature 1997 387 569 572 10.1038/42408 9177342 (Pubitemid 27248754)
4. The fine structure of the gall bladder epithelium of the mouse. Yamada E, J Biophys Biochem Cytol 1955 1 445 458 10.1083/jcb.1.5.445 13263332
5. Fine structure of blood capillaries. Palade GE, J Appl Phys 1953 24 1424 1424
6. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Patel HH, Murray F, Insel PA, Annu Rev Pharmacol Toxicol 2008 48 359 391 10.1146/annurev.pharmtox.48.121506.124841 17914930 (Pubitemid 351738158)
7. Caveolin, a protein component of caveolae membrane coats. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG, Cell 1992 68 673 682 10.1016/0092-8674(92)90143-Z 1739974
8. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Fra AM, Williamson E, Simons K, Parton RG, Proc Natl Acad Sci USA 1995 92 8655 8659 10.1073/pnas.92.19.8655 7567992
9. VIP21/caveolin is a cholesterol-binding protein. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K, Proc Natl Acad Sci USA 1995 92 10339 10343 10.1073/pnas.92.22.10339 7479780
10. Cholesterol and caveolae: structural and functional relationships. Fielding CJ, Fielding PE, Biochim Biophys Acta 2000 1529 210 222 10.1016/S1388-1981(00)00150-5 11111090
11. Caveolins and cellular cholesterol balance. Ikonen E, Parton RG, Traffic 2000 1 212 217 10.1034/j.1600-0854.2000.010303.x 11208104
12. Mitochondrial cholesterol: a connection between caveolin, metabolism, and disease. Bosch M, Mari M, Gross SP, Fernandez-Checa JC, Pol A, Traffic 2011 12 1483 1489 10.1111/j.1600-0854.2011.01259.x 21801290
13. Caveolae and sorting in the trans-Golgi network of epithelial cells. Dupree P, Parton RG, Raposo G, Kurzchalia TV, Simons K, EMBO J 1993 12 1597 1605 8385608 (Pubitemid 23112814)
14. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Monier S, Parton RG, Vogel F, Behlke J, Henske A, Kurzchalia TV, Mol Biol Cell 1995 6 911 927 7579702
15. Caveolins: structure and function in signal transduction. Krajewska WM, Maslowska I, Cell Mol Biol Lett 2004 9 195 220 15213803 (Pubitemid 38902217)
16. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF, J Cell Biol 1994 127 1233 1243 10.1083/jcb.127.5.1233 7962086 (Pubitemid 24362559)
17. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP, Proc Natl Acad Sci USA 1996 93 131 135 10.1073/pnas.93.1.131 8552590 (Pubitemid 26041482)
18. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP, J Biol Chem 1997 272 29337 29346 10.1074/jbc.272.46. 29337 9361015 (Pubitemid 27498228)
19. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP, J Biol Chem 1996 271 15160 15165 10.1074/jbc.271.25.15160 8663016 (Pubitemid 26197582)
20. Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. Kandror KV, Stephens JM, Pilch PF, J Cell Biol 1995 129 999 1006 10.1083/jcb.129.4.999 7744970
21. Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Griffoni C, Spisni E, Santi S, Riccio M, Guarnieri T, Tomasi V, Biochem Biophys Res Commun 2000 276 756 761 10.1006/bbrc.2000.3484 11027543
22. Immunolocalization of caveolin-1 and caveolin-3 in monkey skeletal, cardiac and uterine smooth muscles. Hagiwara Y, Nishina Y, Yorifuji H, Kikuchi T, Cell Struct Funct 2002 27 375 382 10.1247/csf.27.375 12502892 (Pubitemid 36149992)
23. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP, Proc Natl Acad Sci USA 1998 95 10257 10262 10.1073/pnas.95.17.10257 9707634 (Pubitemid 28415328)
24. Identification of caveolin and caveolin-related proteins in the brain. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS, J Neurosci 1997 17 9520 9535 9391007 (Pubitemid 28006396)
25. Identification of caveolae and detection of caveolin in normal human osteoblasts. Lofthouse RA, Davis JR, Frondoza CG, Jinnah RH, Hungerford DS, Hare JM, J Bone Joint Surg Br 2001 83 124 129 10.1302/0301-620X.83B1.10604 11245520 (Pubitemid 32170977)
26. Caveolae in human and murine osteoblasts. Solomon KR, Adolphson LD, Wank DA, McHugh KP, Hauschka PV, J Bone Miner Res 2000 15 2391 2401 10.1359/jbmr.2000.15.12.2391 11127204
27. Characterisation of caveolins from cartilage: expression of caveolin-1, -2 and -3 in chondrocytes and in alginate cell culture of the rat tibia. Schwab W, Galbiati F, Volonte D, Hempel U, Wenzel KW, Funk RH, Lisanti MP, Kasper M, Histochem Cell Biol 1999 112 41 49 10.1007/s004180050390 10461811 (Pubitemid 29356303)
28. Characterization of caveolins from human knee joint cartilage: expression of caveolin-1, -2, and -3 in chondrocytes and association with integrin beta1. Schwab W, Kasper M, Gavlik JM, Schulze E, Funk RH, Shakibaei M, Histochem Cell Biol 2000 113 221 225 10.1007/s004180050441 10817676 (Pubitemid 30196533)
29. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP, J Biol Chem 2001 276 38121 38138 11457855
30. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP, J Biol Chem 1996 271 2255 2261 10.1074/jbc.271.4.2255 8567687 (Pubitemid 26047818)
31. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M, Trends Cell Biol 1994 4 231 235 10.1016/0962-8924(94)90114-7 14731661 (Pubitemid 24190653)
32. Caveolin is an activator of insulin receptor signaling. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG Jr, Ishikawa Y, J Biol Chem 1998 273 26962 26968 10.1074/jbc.273.41.26962 9756945 (Pubitemid 28471718)
33. Intracellular cholesterol transport in synchronized human skin fibroblasts. Fielding CJ, Bist A, Fielding PE, Biochemistry 1999 38 2506 2513 10.1021/bi981012o 10029545 (Pubitemid 29102812)
34. Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. Fujita Y, Maruyama S, Kogo H, Matsuo S, Fujimoto T, Kidney Int 2004 66 1794 1804 10.1111/j.1523-1755.2004.00954.x 15496150 (Pubitemid 41094303)
35. Reduction of caveolin and caveolae in oncogenically transformed cells. Koleske AJ, Baltimore D, Lisanti MP, Proc Natl Acad Sci USA 1995 92 1381 1385 10.1073/pnas.92.5.1381 7877987
36. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP, J Biol Chem 1997 272 16374 16381 10.1074/jbc.272.26.16374 9195944 (Pubitemid 27276462)
37. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP, EMBO J 1998 17 6633 6648 10.1093/emboj/17.22.6633 9822607 (Pubitemid 28521797)
38. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP, Mol Biol Cell 2001 12 2229 2244 10.1091/mbc.12.8.2229 11514613 (Pubitemid 33051953)
39. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, Frank PG, Sotgia F, Lisanti MP, Cell Cycle 2005 4 1817 1825 10.4161/cc.4.12.2199 16294037 (Pubitemid 41827329)
40. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP, Cell Cycle 2005 4 1808 1816 10.4161/cc.4.12.2198 16294019 (Pubitemid 41827328)
41. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain. Jasmin JF, Yang M, Iacovitti L, Lisanti MP, Cell Cycle 2009 8 3978 3983 10.4161/cc.8.23.10206 19923909
42. Mechanical activation of beta-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells. Case N, Xie Z, Sen B, Styner M, Zou M, O'Conor C, Horowitz M, Rubin J, J Orthop Res 2010 28 1531 1538 10.1002/jor.21156 20872592
43. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Samarasinghe RA, Di Maio R, Volonte D, Galbiati F, Lewis M, Romero G, DeFranco DB, Proc Natl Acad Sci USA 2011 108 16657 16662 10.1073/pnas.1102821108 21930911
44. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Park JS, Kim HY, Kim HW, Chae GN, Oh HT, Park JY, Shim H, Seo M, Shin EY, Kim EG, Park SC, Kwak SJ, Mech Ageing Dev 2005 126 551 559 10.1016/j.mad.2004.11.014 15811424 (Pubitemid 40461954)
45. Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. Baker N, Zhang G, You Y, Tuan RS, J Cell Biochem 2012 113 3773 3787 10.1002/jcb.24252 22807396
46. Lipid rafts play an important role for maintenance of embryonic stem cell self-renewal. Lee MY, Ryu JM, Lee SH, Park JH, Han HJ, J Lipid Res 2010 51 2082 2089 10.1194/jlr.M001545 20110442
47. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. Park JH, Ryu JM, Han HJ, J Cell Physiol 2011 226 267 275 10.1002/jcp.22338 20658539
48. A potential role for caveolin-1 in estradiol-17β-induced proliferation of mouse embryonic stem cells: involvement of Src, PI3K/Akt, and MAPKs pathways. Park JH, Lee MY, Han HJ, Int J Biochem Cell Biol 2009 41 659 665 10.1016/j.biocel.2008.07.010 18694845
49. Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK. Park JH, Han HJ, Am J Physiol Cell Physiol 2009 297 935 C944 10.1152/ajpcell.00121.2009 19625610
50. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG, Lisanti MP, J Biol Chem 2000 275 23368 23377 10.1074/jbc.M002020200 10816572 (Pubitemid 30646240)
51. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Lu Z, Ghosh S, Wang Z, Hunter T, Cancer Cell 2003 4 499 515 10.1016/S1535-6108(03)00304-0 14706341 (Pubitemid 38050046)
52. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef- dependent transcription. Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF, Mol Cell Biol 2007 27 7703 7717 10.1128/MCB.01991-06 17785436 (Pubitemid 350033675)
53. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Rodriguez DA, Tapia JC, Fernandez JG, Torres VA, Munoz N, Galleguillos D, Leyton L, Quest AF, Mol Biol Cell 2009 20 2297 2310 10.1091/mbc.E08-09-0939 19244345
54. Caveolin-1 regulates dorsoventral patterning through direct interaction with beta-catenin in zebrafish. Mo S, Wang L, Li Q, Li J, Li Y, Thannickal VJ, Cui Z, Dev Biol 2010 344 210 223 10.1016/j.ydbio.2010.04.033 20452340
55. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP, J Biol Chem 2001 276 6727 6738 10.1074/jbc.M008340200 11102446
56. Endocytic regulation of TGF-beta signaling. Chen YG, Cell Res 2009 19 58 70 10.1038/cr.2008.315 19050695
57. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Del Galdo F, Lisanti MP, Jimenez SA, Curr Opin Rheumatol 2008 20 713 719 10.1097/BOR.0b013e3283103d27 18949888
58. Caveolin-1 increases basal and TGF-β1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Kim S, Lee Y, Seo JE, Cho KH, Chung JH, Cell Signal 2008 20 1313 1319 10.1016/j.cellsig.2008.02.020 18434090
59. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae. Santibanez JF, Blanco FJ, Garrido-Martin EM, Sanz-Rodriguez F, del Pozo MA, Bernabeu C, Cardiovasc Res 2008 77 791 799 18065769 (Pubitemid 351301871)
60. Expression of caveolin-1 reduces cellular responses to TGF-β1 through down-regulating the expression of TGF-β type II receptor gene in NIH3T3 fibroblast cells. Lee EK, Lee YS, Han IO, Park SH, Biochem Biophys Res Commun 2007 359 385 390 10.1016/j.bbrc.2007.05.121 17543885 (Pubitemid 46880518)
61. Distinct role of endocytosis for Smad and non-Smad TGF-beta signaling regulation in hepatocytes. Meyer C, Godoy P, Bachmann A, Liu Y, Barzan D, Ilkavets I, Maier P, Herskind C, Hengstler JG, Dooley S, J Hepatol 2011 55 369 378 10.1016/j.jhep.2010.11.027 21184784
62. TGFβ-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Peng F, Zhang B, Wu D, Ingram AJ, Gao B, Krepinsky JC, Am J Physiol Renal Physiol 2008 295 153 F164 10.1152/ajprenal.00419.2007 18434385
63. Dynamics and interaction of caveolin-1 isoforms with BMP-receptors. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO, J Cell Sci 2005 118 643 650 10.1242/jcs.01402 15657086 (Pubitemid 40310130)
64. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S, Henis YI, Knaus P, Mol Cell Biol 2006 26 7791 7805 10.1128/MCB.00022-06 16923969 (Pubitemid 44547724)
65. Caveolin-1 regulates BMPRII localization and signaling in vascular smooth muscle cells. Wertz JW, Bauer PM, Biochem Biophys Res Commun 2008 375 557 561 10.1016/j.bbrc.2008.08.066 18725205
66. Initiation of BMP2 signaling in domains on the plasma membrane. Bonor J, Adams EL, Bragdon B, Moseychuk O, Czymmek KJ, Nohe A, J Cell Physiol 2012 227 2880 2888 10.1002/jcp.23032 21938723
67. Caveolin-1 isoform reorganization studied by image correlation spectroscopy. Nohe A, Keating E, Loh C, Underhill MT, Petersen NO, Faraday Discuss 2004 126 185 195 discussion 245-254 14992406 (Pubitemid 38365593)
68. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. Matveev S, van der Westhuyzen DR, Smart EJ, J Lipid Res 1999 40 1647 1654 10484611 (Pubitemid 29418705)
69. Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies. Ng YS, Ramsauer M, Loureiro RM, D'Amore PA, Lab Invest 2004 84 1209 1218 10.1038/labinvest.3700150 15220937 (Pubitemid 39128266)
70. Caveolin-1 expression enhances endothelial capillary tubule formation. Liu J, Wang XB, Park DS, Lisanti MP, J Biol Chem 2002 277 10661 10668 10.1074/jbc.M110354200 11748236 (Pubitemid 34968193)
71. Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures. Campbell L, Hollins AJ, Al-Eid A, Newman GR, von Ruhland C, Gumbleton M, Biochem Biophys Res Commun 1999 262 744 751 10.1006/bbrc.1999.1280 10471396 (Pubitemid 29443729)
72. Differentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C. Fuchs S, Hollins AJ, Laue M, Schaefer UF, Roemer K, Gumbleton M, Lehr CM, Cell Tissue Res 2003 311 31 45 10.1007/s00441-002-0653-5 12483282 (Pubitemid 35478222)
73. Caveolin-1 regulates neural differentiation of rat bone mesenchymal stem cells into neurons by modulating Notch signaling. Wang S, Kan Q, Sun Y, Han R, Zhang G, Peng T, Jia Y, Int J Dev Neurosci 2013 31 30 35 10.1016/j.ijdevneu. 2012.09.004 23031836
74. Caveolin-1 knockout mice have increased bone size and stiffness. Rubin J, Schwartz Z, Boyan BD, Fan X, Case N, Sen B, Drab M, Smith D, Aleman M, Wong KL, Yao H, Jo H, Gross TS, J Bone Miner Res 2007 22 1408 1418 10.1359/jbmr.070601 17550335 (Pubitemid 351339685)
75. Caveolin-1 inhibits oligodendroglial differentiation of neural stem/progenitor cells through modulating beta-catenin expression. Li Y, Lau WM, So KF, Tong Y, Shen J, Neurochem Int 2011 59 114 121 10.1016/j.neuint.2011.05. 019 21693146
76. Caveolin-1 plays a crucial role in inhibiting neuronal differentiation of neural stem/progenitor cells via VEGF signaling-dependent pathway. Li Y, Luo J, Lau WM, Zheng G, Fu S, Wang TT, Zeng HP, So KF, Chung SK, Tong Y, Liu K, Shen J, PLoS One 2011 6 22901 10.1371/journal.pone.0022901 21826216
77. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. Kha HT, Basseri B, Shouhed D, Richardson J, Tetradis S, Hahn TJ, Parhami F, J Bone Miner Res 2004 19 830 840 10.1359/jbmr.040115 15068507 (Pubitemid 41094395)
78. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Song C, Guo Z, Ma Q, Chen Z, Liu Z, Jia H, Dang G, Biochem Biophys Res Commun 2003 308 458 462 10.1016/S0006-291X(03)01408-6 12914771 (Pubitemid 36945513)
79. The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells. Baek KH, Lee WY, Oh KW, Tae HJ, Lee JM, Lee EJ, Han JH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, J Korean Med Sci 2005 20 438 444 10.3346/jkms.2005.20.3.438 15953866
80. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Fielding CJ, Bist A, Fielding PE, Proc Natl Acad Sci USA 1997 94 3753 3758 10.1073/pnas.94.8.3753 9108050 (Pubitemid 27180445)
81. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. Smart EJ, Ying YS, Conrad PA, Anderson RG, J Cell Biol 1994 127 1185 1197 10.1083/jcb.127.5.1185 7962084 (Pubitemid 24362556)
82. Altered plasma membrane dynamics of bone morphogenetic protein receptor type Ia in a low bone mass mouse model. Bragdon B, D'Angelo A, Gurski L, Bonor J, Schultz KL, Beamer WG, Rosen CJ, Nohe A, Bone 2012 50 189 199 10.1016/j.bone.2011.10.016 22036911
83. Bone morphogenetic protein receptor type Ia localization causes increased BMP2 signaling in mice exhibiting increased peak bone mass phenotype. Bragdon B, Bonor J, Shultz KL, Beamer WG, Rosen CJ, Nohe A, J Cell Physiol 2012 227 2870 2879 10.1002/jcp.23028 22170575
84. Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity. Du J, Chen X, Liang X, Zhang G, Xu J, He L, Zhan Q, Feng XQ, Chien S, Yang C, Proc Natl Acad Sci USA 2011 108 9466 9471 10.1073/pnas.1106467108 21593411
85. Matrix elasticity directs stem cell lineage specification. Engler AJ, Sen S, Sweeney HL, Discher DE, Cell 2006 126 677 689 10.1016/j.cell.2006.06.044 16923388 (Pubitemid 44233625)
86. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P, Nguyen NK, Thrun S, Lutolf MP, Blau HM, Science 2010 329 1078 1081 10.1126/science.1191035 20647425
87. Caveolin-1 promote astroglial differentiation of neural stem/progenitor cells through modulating Notch1/NICD and Hes1 expressions. Li Y, Lau WM, So KF, Tong Y, Shen J, Biochem Biophys Res Commun 2011 407 517 524 10.1016/j.bbrc.2011. 03.050 21414292
88. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. Park DS, Lee H, Riedel C, Hulit J, Scherer PE, Pestell RG, Lisanti MP, J Biol Chem 2001 276 48389 48397 11602600
89. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG, Lisanti MP, Mol Biol Cell 2002 13 3416 3430 10.1091/mbc.02-05-0071 12388746 (Pubitemid 35191364)
90. The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. Volonte D, Liu Y, Galbiati F, FASEB J 2005 19 237 239 15545301 (Pubitemid 40189267)
91. Caveolin-1 as a novel indicator of wound-healing capacity in aged human corneal epithelium. Rhim JH, Kim JH, Yeo EJ, Kim JC, Park SC, Mol Med 2010 16 527 534 20644900
92. Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy. Mikol DD, Scherer SS, Duckett SJ, Hong HL, Feldman EL, Glia 2002 38 191 199 10.1002/glia.10063 11968057
93. Caveolin-1 modulates TGF-beta1 signaling in cardiac remodeling. Miyasato SK, Loeffler J, Shohet R, Zhang J, Lindsey M, Le Saux CJ, Matrix Biol 2011 30 318 329 10.1016/j.matbio.2011.05.003 21641995
94. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Ratajczak P, Damy T, Heymes C, Oliviero P, Marotte F, Robidel E, Sercombe R, Boczkowski J, Rappaport L, Samuel JL, Cardiovasc Res 2003 57 358 369 10.1016/S0008-6363(02)00660-0 12566108 (Pubitemid 36144214)
95. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. Young LH, Ikeda Y, Lefer AM, Am J Physiol Heart Circ Physiol 2001 280 2489 H2495 11356603
96. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP, Am J Pathol 2003 162 2059 2068 10.1016/S0002-9440(10)64337-4 12759260 (Pubitemid 36613061)
97. Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress. Milovanova T, Chatterjee S, Hawkins BJ, Hong N, Sorokina EM, Debolt K, Moore JS, Madesh M, Fisher AB, Biochim Biophys Acta 2008 1783 1866 1875 10.1016/j.bbamcr.2008.05.010 18573285
98. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Gregoire V, Dessy C, Balligand JL, Feron O, Circ Res 2004 95 154 161 10.1161/01.RES.0000136344.27825.72 15205364 (Pubitemid 38988681)
99. Caveolin-1 deficiency increases cerebral ischemic injury. Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP, Circ Res 2007 100 721 729 10.1161/01.RES.0000260180.42709.29 17293479 (Pubitemid 46594887)
100. Caveolin-1 is essential for liver regeneration. Fernandez MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T, Tebar F, Enrich C, Parton RG, Pol A, Science 2006 313 1628 1632 10.1126/science.1130773 16973879 (Pubitemid 44414035)
101. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells. Mayoral R, Fernandez-Martinez A, Roy R, Bosca L, Martin-Sanz P, Hepatology 2007 46 813 822 10.1002/hep.21746 17654701 (Pubitemid 47436128)
102. Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration. Mayoral R, Valverde AM, Llorente Izquierdo C, Gonzalez-Rodriguez A, Bosca L, Martin-Sanz P, J Biol Chem 2010 285 3633 3642 10.1074/jbc.M109.072900 19966340
103. Immunohistochemical study on caveolin-1α in regenerating process of tubular cells in gentamicin-induced acute tubular injury in rats. Fujigaki Y, Sakakima M, Sun Y, Goto T, Ohashi N, Fukasawa H, Tsuji T, Yamamoto T, Hishida A, Virchows Arch 2007 450 671 681 10.1007/s00428-007-0417-4 17464513 (Pubitemid 46986232)
104. A syndecan-4 hair trigger initiates wound healing through caveolin- and RhoG-regulated integrin endocytosis. Bass MD, Williamson RC, Nunan RD, Humphries JD, Byron A, Morgan MR, Martin P, Humphries MJ, Dev Cell 2011 21 681 693 10.1016/j.devcel.2011.08.007 21982645
105. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA, J Cell Biol 2007 177 683 694 10.1083/jcb.200701006 17517963 (Pubitemid 46799839)
106. The 'caveolae brake hypothesis' and the epidermal barrier. Roelandt T, Giddelo C, Heughebaert C, Denecker G, Hupe M, Crumrine D, Kusuma A, Haftek M, Roseeuw D, Declercq W, Feingold KR, Elias PM, Hachem JP, J Invest Dermatol 2009 129 927 936 10.1038/jid.2008.328 19005485
107. Caveolin-1 in cell polarization and directional migration. Grande-Garcia A, del Pozo MA, Eur J Cell Biol 2008 87 641 647 10.1016/j.ejcb.2008.02.001 18375013
108. Fibronectin stimulates migration through lipid raft dependent NHE-1 activation in mouse embryonic stem cells: involvement of RhoA, Ca§ssup§2+§esup§/CaM, and ERK. Park JH, Ryu JM, Yun SP, Kim MO, Han HJ, Biochim Biophys Acta 1820 2012 1618 1627
109. Mesenchymal stem cells, used as bait, disclose tissue binding sites: a tool in the search for the niche? Ratliff BB, Singh N, Yasuda K, Park HC, Addabbo F, Ghaly T, Rajdev M, Jasmin JF, Plotkin M, Lisanti MP, Goligorsky MS, Am J Pathol 2010 177 873 883 10.2353/ajpath.2010.090984 20558574
110. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M, Mills M, Wanzeck J, Janowska-Wieczorek A, Ratajczak MZ, Blood 2005 105 40 48 10.1182/blood-2004-04-1430 15328152 (Pubitemid 40053061)
111. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Sbaa E, Dewever J, Martinive P, Bouzin C, Frerart F, Balligand JL, Dessy C, Feron O, Circ Res 2006 98 1219 1227 10.1161/01.RES.0000220648.80170.8b 16601228 (Pubitemid 43948109)
112. Oxidative stress and aging: beyond correlation. Golden TR, Hinerfeld DA, Melov S, Aging Cell 2002 1 117 123 10.1046/j.1474-9728.2002.00015.x 12882341
113. Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. Bosch M, Mari M, Herms A, Fernandez A, Fajardo A, Kassan A, Giralt A, Colell A, Balgoma D, Barbero E, Gonzalez-Moreno E, Matias N, Tebar F, Balsinde J, Camps M, Enrich C, Gross SP, Garcia-Ruiz C, Perez-Navarro E, Fernandez-Checa JC, Pol A, Curr Biol 2011 21 681 686 10.1016/j.cub.2011.03.030 21497090
114. Loss of caveolin-1 accelerates neurodegeneration and aging. Head BP, Peart JN, Panneerselvam M, Yokoyama T, Pearn ML, Niesman IR, Bonds JA, Schilling JM, Miyanohara A, Headrick J, Ali SS, Roth DM, Patel PM, Patel HH, PLoS One 2010 5 15697 10.1371/journal.pone.0015697 21203469
115. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, Blagosklonny MV, Lisanti MP, Am J Pathol 2012 181 278 293 10.1016/j.ajpath.2012.03.017 22698676
116. Taking a 'good' look at free radicals in the aging process. Hekimi S, Lapointe J, Wen Y, Trends Cell Biol 2011 21 569 576 10.1016/j.tcb.2011.06.008 21824781
117. Role of caveolin and caveolae in insulin signaling and diabetes. Cohen AW, Combs TP, Scherer PE, Lisanti MP, Am J Physiol Endocrinol Metab 2003 285 1151 E1160 14607781
118. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP, Am J Physiol Cell Physiol 2003 285 222 C235 10.1152/ajpcell.00006.2003 12660144
119. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP, J Biol Chem 2002 277 8635 8647 10.1074/jbc.M110970200 11739396 (Pubitemid 34968330)
120. Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells. Park WY, Park JS, Cho KA, Kim DI, Ko YG, Seo JS, Park SC, J Biol Chem 2000 275 20847 20852 10.1074/jbc.M908162199 10781609 (Pubitemid 30457678)
121. Senescent phenotype can be reversed by reduction of caveolin status. Cho KA, Ryu SJ, Park JS, Jang IS, Ahn JS, Kim KT, Park SC, J Biol Chem 2003 278 27789 27795 10.1074/jbc.M208105200 12730243 (Pubitemid 36899970)
122. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T, Nature 2011 477 90 94 10.1038/nature10357 21886162
123. Extending healthy life span-from yeast to humans. Fontana L, Partridge L, Longo VD, Science 2010 328 321 326 10.1126/science.1172539 20395504
124. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens. Gyurus E, Kaposztas Z, Kahan BD, Transplant Proc 2011 43 1583 1592 10.1016/j.transproceed. 2011.05.001 21693238
125. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA, Nature 2009 460 392 395 19587680
126. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Chen C, Liu Y, Zheng P, Sci Signal 2009 2 a75 10.1126/scisignal.2000559 19934433
127. Aging, stem cells and tissue regeneration: lessons from muscle. Conboy IM, Rando TA, Cell Cycle 2005 4 407 410 10.4161/cc.4.3.1518 15725724 (Pubitemid 41359725)
128. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA, Nature 2005 433 760 764 10.1038/nature03260 15716955 (Pubitemid 40292986)
129. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA, Science 2007 317 807 810 10.1126/science.1144090 17690295 (Pubitemid 47257918)
130. Increase of cholesterol turnover of old rats connected by parabiosis with young rats. Hruza Z, Exp Gerontol 1971 6 103 107 10.1016/0531-5565(71)90054-4 5572734
131. Role of mechanical factors in fate decisions of stem cells. Li D, Zhou J, Chowdhury F, Cheng J, Wang N, Wang F, Regen Med 2011 6 229 240 10.2217/rme.11.2 21391856
132. Mapping the mechanome of live stem cells using a novel method to measure local strain fields in situ at the fluid-cell interface. Song MJ, Brady-Kalnay SM, McBride SH, Phillips-Mason P, Dean D, Knothe Tate ML, PLoS One 2012 7 43601 10.1371/journal.pone.0043601 22970134
133. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. Rizzo V, Sung A, Oh P, Schnitzer JE, J Biol Chem 1998 273 26323 26329 10.1074/jbc.273.41.26323 9756862 (Pubitemid 28471635)
134. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, Braun-Dullaeus RC, Circ Res 2005 96 635 642 10.1161/01.RES.0000160610.61306.0f 15731459 (Pubitemid 40478330)
135. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC, J Clin Invest 2006 116 1284 1291 10.1172/JCI27100 16670769
136. p190 RhoGTPase-activating protein links the β1 integrin/caveolin-1 mechanosignaling complex to RhoA and actin remodeling. Yang B, Radel C, Hughes D, Kelemen S, Rizzo V, Arterioscler Thromb Vasc Biol 2011 31 376 383 10.1161/ATVBAHA.110.217794 21051664
137. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Radel C, Rizzo V, Am J Physiol Heart Circ Physiol 2005 288 936 H945 15471980
138. Participation of caveolae in beta1 integrin-mediated mechanotransduction. Radel C, Carlile-Klusacek M, Rizzo V, Biochem Biophys Res Commun 2007 358 626 631 10.1016/j.bbrc.2007.04.179 17498653 (Pubitemid 46755750)
139. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Kawabe J, Okumura S, Lee MC, Sadoshima J, Ishikawa Y, Am J Physiol Heart Circ Physiol 2004 286 1845 H1852 10.1152/ajpheart.00593. 2003 15072971 (Pubitemid 38525474)
140. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. Kawamura S, Miyamoto S, Brown JH, J Biol Chem 2003 278 31111 31117 10.1074/jbc.M300725200 12777392 (Pubitemid 36994626)
141. Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells. Zhang B, Peng F, Wu D, Ingram AJ, Gao B, Krepinsky JC, Cell Signal 2007 19 1690 1700 10.1016/j.cellsig.2007.03.005 17446044 (Pubitemid 46935426)
142. RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction. Peng F, Wu D, Ingram AJ, Zhang B, Gao B, Krepinsky JC, J Am Soc Nephrol 2007 18 189 198 10.1681/ASN.2006050498 17121865 (Pubitemid 46053432)
143. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Plotkin LI, Mathov I, Aguirre JI, Parfitt AM, Manolagas SC, Bellido T, Am J Physiol Cell Physiol 2005 289 633 C643 10.1152/ajpcell.00278.2004 15872009 (Pubitemid 41192673)
144. Depletion of plasma membrane cholesterol dampens hydrostatic pressure and shear stress-induced mechanotransduction pathways in osteoblast cultures. Ferraro JT, Daneshmand M, Bizios R, Rizzo V, Am J Physiol Cell Physiol 2004 286 831 C839 10.1152/ajpcell.00224.2003 14644772
145. Caveolae act as membrane reserves which limit mechanosensitive I(Cl, swell) channel activation during swelling in the rat ventricular myocyte. Kozera L, White E, Calaghan S, PLoS One 2009 4 8312 10.1371/journal.pone.0008312 20011535
146. Effects of acute ventricular volume manipulation on in situ cardiomyocyte cell membrane configuration. Kohl P, Cooper PJ, Holloway H, Prog Biophys Mol Biol 2003 82 221 227 10.1016/S0079-6107(03)00024-5 12732281 (Pubitemid 36551218)
147. Cells respond to mechanical stress by rapid disassembly of caveolae. Sinha B, Koster D, Ruez R, Gonnord P, Bastiani M, Abankwa D, Stan RV, Butler-Browne G, Vedie B, Johannes L, Morone N, Parton RG, Raposo G, Sens P, Lamaze C, Nassoy P, Cell 2011 144 402 413 10.1016/j.cell.2010.12.031 21295700